Strategic Market Access; Patient-Reported Outcomes
Rotterdam, The Netherlands
Krystallia Pantiri is a Research Consultant in the Rotterdam office, the Netherlands. Krystallia works within the Strategic Market Access and Patient-Reported Outcomes/Clinical Outcomes Assessment (PRO/COA) Centers of Excellence. Her main expertise is in conducting (systematic) literature reviews to inform network meta-analyses, global value dossiers and reimbursement dossiers.
Krystallia has experience with reviews of epidemiology, disease burden and treatment patterns, using the results as input for landscape analyses, strategic advice and value story development. Her experience also includes qualitative patient reported outcomes (PRO) research. She has been involved in international projects for the development and validation of PRO instruments. Disease areas she has worked in include vaccines, inflammatory disease, respiratory diseases, oncology, haematology, neurological disorders and orphan diseases. She has presented work at ISPOR and ISOQOL. Krystallia holds a BSc degree in Economics (University of Macedonia, Thessaloniki, Greece, 2010) and a MSc degree in Health Economics, Policy and Law (Erasmus University Rotterdam, the Netherlands, 2012).